Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 13/20 | 0.52 |
| ▸ | CA2 | P00918 | 13/20 | 0.52 |
| ▸ | MMP1 | P03956 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | MMP8 | P22894 | 1/20 | 0.45 |
| ▸ | MMP13 | P45452 | 1/20 | 0.45 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.37 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.34 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25782122 | 0.90 | CA1 (0.47) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL23841421 | 0.84 | CA1 (0.39) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL25068896 | 0.83 | CA1 (0.52) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL13588295 | 0.83 | CA1 (0.52) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL12129751 | 0.83 | CA1 (0.56) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL25068916 | 0.80 | CA1 (0.48) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL26430396 | 0.80 | CA1 (0.48) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL25117883 | 0.80 | CA1 (0.32) | CA1CA2 | |
| SCHEMBL12639755 | 0.79 | CA2 (0.47) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL2347469 | 0.77 | CA1 (0.71) | CA1CA2MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230217677-A1 | Organic Electronic Device Comprising a Substrate, an Anode Layer, a Cathode Layer, at Least One First Emission Layer, and a Hole Injection Layer That Comprises a Metal Complex | NOVALED GMBH (DE) | 2023-07-06 | — | — | US | disclosed |
| US-20230131369-A1 | An Organic Electronic Device Comprising a Hole Injection Layer That Comprises a Hole Transport Compound | NOVALED GMBH (DE) | 2023-04-27 | — | — | US | disclosed |
| US-20230056322-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | NOVALED GMBH (DE) | 2023-02-23 | — | — | US | disclosed |
| EP-4002508-A1 | ORGANIC ELECTRONIC DEVICE COMPRISING A COMPOUND OF FORMULA (1), DISPLAY DEVICE COMPRISING THE ORGANIC ELECTRONIC DEVICE AS WELL AS COMPOUNDS OF FORMULA (1) FOR USE IN ORGANIC ELECTRONIC DEVICES | Novaled GmbH (DE) | 2022-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230056322-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | AOX1, CYP1B1, CYP1A1 | CA1 1881/4885CA2 3827/4885MMP1 3607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.